LIVE · 2026-09-03 05:20 UTC

HALO Halozyme Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official

Market Value*

$4.50B

Revenue (FY)

$1.40B 2025-12-31

Net Income (FY)

$316.89M

P/E (float-based)

14.2

Revenue History

Net Income History

*Market value = public float disclosed in latest 10-K filing · CIK 1159036 · SEC filings · revenue ranking · home